Get all premium features to the best stock analysis tool

Brookfield Renewable expects to grow its cash flow per share at a more than 10% annual rate over the next five years. Enbridge can deliver 5% annual growth through the end of the decade.

Multiple headwinds could bring the bull market to a halt. Stocks positioned to rise even during a market downturn include Berkshire Hathaway, Enbridge, and Vertex Pharmaceuticals.

Enbridge and MPLX are midstream operators. Both companies offer above-average dividend yields.

Enbridge Inc. remains a compelling long-term income play, despite recent ENB share price gains reducing near-term upside. Q4 and full-year results showed modest growth, with distributable cash flow per share up 4.3% in Q4 and 2.7% for the year. ENB guides for 1%-4% EBITDA growth and flat to +6.8% distributable cash flow per share through 2026, supported by a robust project pipeline.

Zacks.com users have recently been watching Enbridge (ENB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Enbridge Inc. offers attractive US dollar preferred shares with yields up to 6.8%, appealing to income investors seeking return of capital. I am passing on ENB common stock due to its unfocused business mix, particularly the lack of strategic fit for its Renewable Power segment. 98% of ENB's cash flows are non-commodity price based, with 80% of EBITDA from assets with inflation protection, supporting dividend safety for preferred shares.

Enbridge (ENB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.